Will long acting implantable and injectable buprenorphine become widely adopted for opioid addiction treatment? Report Available: April 8, 2016 Blueshift’s initial research shows that addiction to opioids has skyrocketed to the point of being an epidemic. Current available treatment options face numerous challenges including frequent dosing, poor adherence, high incidence of relapse, and misuse. […]
Research Question: Does shifting to a private exchange offer a compelling value proposition for self-insured companies as they seek to control health insurance costs? Companies: AET, CI, CVG, HUM, MMC, TW, UNH, WAG, WLP, XRX By: David Franklin Click here to download the report (.pdf) Summary of Findings Private health insurance exchanges, self-funded health insurance, and defined […]
Copyright © 2015 Blueshift Research, LLC. All rights reserved.